GPS nanoparticle platform precisely delivers therapeutic payload to cancer cells
March 11, 2024
March 11, 2024
UNIVERSITY PARK, Pennsylvania, March 12 -- Pennsylvania State University issued the following news on March 11, 2024:
A newly developed "GPS nanoparticle" injected intravenously can home in on cancer cells to deliver a genetic punch to the protein implicated in tumor growth and spread, according to researchers from Penn State. They tested their approach in human cell lines and in mice to effectively knock down a cancer-causing gene, reporting that the technique may potenti . . .
A newly developed "GPS nanoparticle" injected intravenously can home in on cancer cells to deliver a genetic punch to the protein implicated in tumor growth and spread, according to researchers from Penn State. They tested their approach in human cell lines and in mice to effectively knock down a cancer-causing gene, reporting that the technique may potenti . . .